API TR 405 is a technical report that provides specialized background on An Inhalation Oncogenicity Study of Commercial Hexane in Rats and Mice, Part II—Mice. As part of the API technical literature, it is intended to support informed review of study context, interpretation, and related scientific discussion rather than to set prescriptive requirements. For buyers evaluating relevance, this document may be useful where a deeper technical reference is needed for health, safety, or research-related review of hexane exposure findings. It can also support internal documentation, technical assessment, and cross-functional evaluation.

Purpose of API TR 405

The purpose of API TR 405 is to serve as a technical reference for evaluating the mouse portion of an inhalation oncogenicity study involving commercial hexane. As an API Technical Report, it is primarily meant to provide background and interpretive value that can inform specialist review, rather than operational instructions or compliance requirements. Teams involved in technical documentation, R&D support, safety review, or scientific assessment may use it to better understand the study context and how the findings relate to broader engineering or product stewardship decisions.

How API TR 405 may be used

API TR 405 may be used in technical review work where commercial hexane exposure data and study interpretation are relevant. It can support internal evaluation by engineering, QA/QC, EHS, or technical assurance teams that need a reliable reference for comparing information, documenting findings, or supporting a review process. In practice, it may also assist procurement and project teams when background documentation is needed for material or process decisions tied to health and technical risk considerations. The report is best suited to specialist use where contextual scientific reference matters.

Why API TR 405 matters

API TR 405 matters because it gives professionals a documented technical basis for understanding a specific inhalation oncogenicity study involving commercial hexane in mice. That can improve consistency in internal reviews, help teams compare technical evidence, and support more informed decision-making when exposure-related questions arise. For organizations that manage technical documentation, safety review, or product stewardship, having a focused reference like API TR 405 can reduce uncertainty and strengthen the quality of internal assessment work.

• Technical background on commercial hexane study context
• Mouse-based inhalation oncogenicity reference
• Useful for specialist scientific or safety review
• Supports internal assessment and documentation
• Relevant to EHS, R&D, and technical assurance teams
• API technical report published in 1995